Early dual antibiotics for staph bloodstream infections
Part of Infections clinical trials.
This trial tests whether giving two antibiotics early, instead of the usual one, improves recovery for people with a staph bloodstream infection (a serious bacterial infection in the blood). If you qualify, participation will involve close monitoring and follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult hospitalized at one of the participating WVU Medicine hospitals.
- You have a staph (Staphylococcus aureus) infection in your bloodstream.
- You can attend follow-up lab tests and clinic visits (in person or by video).
- You (or your medical decision-maker) can give informed consent.
- You are not pregnant, a prisoner, or mentally unable to make decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This trial compares two antibiotics, vancomycin and daptomycin, to see which works better for treating MRSA bacteria in the blood. Patients are randomly assigned to one of the drugs and will be monitored closely for results and side effects.
This Phase 2 study tests whether adding ertapenem to cefazolin can improve treatment of staphylococcus (“S. aureus”) bloodstream infection that is likely methicillin-susceptible (MSSA). It aims to start the right antibiotics quickly, before MRSA status is fully confirmed, using early testing and a treatment plan guided by infectious-disease specialists.
This trial tests whether switching from IV to oral antibiotics is just as effective for treating Gram-negative bloodstream infections. If you qualify, you may receive either continued IV antibiotics or switch to pills, with follow-up on your recovery and quality of life.
This trial compares two antibiotics, cloxacillin and benzylpenicillin, to see which works better for patients with a bloodstream infection caused by a specific type of staph bacteria that responds well to penicillin. It may help guide more effective treatment.
Hear when a new Staphylococcus Aureus Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.